SecBot SecBot
3 ·Filed Nov 12, 2026
WW

WWB

WINDWARD BIO GROUP AG
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 4h ago SEC0001776393-26-000005
Actionable Insight • Neutral

These Form 3 filings are standard for insiders of a newly public company. Monitor future Form 4 filings for any insider transactions that could signal conviction or concern.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$28.50
T+0 close · Nov 12, 2026 · via day close
Latest settled
+5.40%
T+1 · $30.04
Vs SPY
+7.32%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $28.50entry
  2. T+1 · 15h ago +5.40%α +7.32% · $30.04
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Form 3 initial beneficial ownership filings were submitted for Windward Bio Group AG by Omar Khwaja (Chief Medical Officer), Otello Stampacchia (director of Omega fund managers), and Sandip Kapadia (director). Khwaja reported 642,136 common shares and options for 318,830 shares; Stampacchia reported indirect ownership of 3,587,520 common shares via Omega Funds VII and VIII; Kapadia reported no securities. These are routine insider initial filings, likely in connection with the company's IPO or listing.

Key Facts

  • Omar Khwaja (Chief Medical Officer) filed Form 3 reporting 642,136 common shares directly owned and options to buy 318,830 shares at $0.02 per share, vesting monthly through April 2036.
  • Otello Stampacchia filed Form 3 reporting indirect beneficial ownership of 3,587,520 common shares through Omega Fund VII, L.P. and Omega Fund VIII, L.P. (combined total of 1,262,628 + 1,262,626 + 531,632 + 531,634 common shares upon conversion of preferred shares).
  • Sandip Kapadia filed Form 3 reporting no securities owned.
  • All three filings include a power of attorney authorizing Scott Applebaum, Diego Ramos, and Claudia D'Augusta to execute future Section 16 filings.
  • The filings were submitted on November 12, 2026, with a period of report of the same date, consistent with an IPO or listing event.

Financial Impact

No financial impact; these are initial ownership disclosures with no transaction or offering.

Risk Factors

  • No material risks identified from these filings.

Documents Analyzed

This report is based on 12 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (WWB), Batch item 10001776393-26-000005
Document: 0001776393-26-000005-index-headers.html0001361712-26-000007
Document: 0001776393-26-000005-index.html0001677141-26-000009
Document: 0001776393-26-000005.txt0001776393-26-000005
3 Filing (WWB), Batch item 50001361712-26-000007
Document: 0001361712-26-000007-index-headers.html0001776393-26-000005
Document: 0001361712-26-000007-index.html0001776393-26-000005
Document: 0001361712-26-000007.txt0001776393-26-000005
3 Filing (WWB), Batch item 90001677141-26-000009
Document: 0001677141-26-000009-index-headers.html0001776393-26-000005
Document: 0001677141-26-000009-index.html0001776393-26-000005
Document: 0001677141-26-000009.txt0001776393-26-000005

US Market Status

Market Closed · Opens Wed (11h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026